Frequent activation of mammalian target of rapamycin in primary lung adenocarcinoma and preinvasive lesion

Younghye Kim, Hoiseon Jeong, Aeree Kim, Han Kyeom Kim, Bong Kyung Shin

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background and aim: The mammalian target of rapamycin (mTOR) pathway is important for cell survival, growth and proliferation and may be involved in the histological progression of lung adenocarcinoma (AC). Methods: We compared the expression of the mTOR signal pathway molecules, i.e., phosphorylated m-TOR (p-mTOR), phosphatase and tensin homolog deleted on chromosome ten (PTEN), epidermal growth factor receptor (EGFR), and cyclin D1, among lung AC, adenocarcinoma in situ (AIS) including both pure bronchioloalveolar carcinoma (BAC) and peripheral BAC-like lesions around invasive carcinoma, atypical adenomatous hyperplasia (AAH), and normal parenchyma surrounding tumor by immunohistochemistry. The protein expression was also correlated with patients' clinicopathological data on smoking history, tumor stage at diagnosis, recurrence and survival. Results: Intermediate or strong immunoreactivity for p-mTOR was seen in 84.1% of AC and 90.2% of AIS. Partial or complete loss of PTEN was demonstrated in 88.8% of AC and 30.4% of AIS. A significant trend of increasing EGFR, loss of PTEN, p53 expression and Ki-67 labeling index were observed by histological progression from AAH to invasive AC through AIS. Expression of p-mTOR was associated with smoking status. Conclusions: Activation of mTOR can occur by various stimuli and may be an early event in the carcinogenesis of lung AC, and may be associated with sex and smoking status of the patient.

Original languageEnglish
Pages (from-to)78-85
Number of pages8
JournalBasic and Applied Pathology
Volume4
Issue number3
DOIs
Publication statusPublished - 2011 Sep 1

Fingerprint

Sirolimus
Bronchiolo-Alveolar Adenocarcinoma
Adenocarcinoma
Smoking
Epidermal Growth Factor Receptor
Hyperplasia
Cyclin D1
Phosphoric Monoester Hydrolases
Signal Transduction
Neoplasms
Cell Survival
Carcinogenesis
Chromosomes
History
Immunohistochemistry
Cell Proliferation
Carcinoma
Recurrence
Survival
Adenocarcinoma in Situ

Keywords

  • Adenocarcinoma
  • Epidermal growth factor receptor
  • Lung
  • Mammalian target of rapamycin
  • Phosphatase and tensin homolog deleted on chromosome ten

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Frequent activation of mammalian target of rapamycin in primary lung adenocarcinoma and preinvasive lesion. / Kim, Younghye; Jeong, Hoiseon; Kim, Aeree; Kim, Han Kyeom; Shin, Bong Kyung.

In: Basic and Applied Pathology, Vol. 4, No. 3, 01.09.2011, p. 78-85.

Research output: Contribution to journalArticle

@article{0b4963f82b3f45b0b485c0dc20fda63a,
title = "Frequent activation of mammalian target of rapamycin in primary lung adenocarcinoma and preinvasive lesion",
abstract = "Background and aim: The mammalian target of rapamycin (mTOR) pathway is important for cell survival, growth and proliferation and may be involved in the histological progression of lung adenocarcinoma (AC). Methods: We compared the expression of the mTOR signal pathway molecules, i.e., phosphorylated m-TOR (p-mTOR), phosphatase and tensin homolog deleted on chromosome ten (PTEN), epidermal growth factor receptor (EGFR), and cyclin D1, among lung AC, adenocarcinoma in situ (AIS) including both pure bronchioloalveolar carcinoma (BAC) and peripheral BAC-like lesions around invasive carcinoma, atypical adenomatous hyperplasia (AAH), and normal parenchyma surrounding tumor by immunohistochemistry. The protein expression was also correlated with patients' clinicopathological data on smoking history, tumor stage at diagnosis, recurrence and survival. Results: Intermediate or strong immunoreactivity for p-mTOR was seen in 84.1{\%} of AC and 90.2{\%} of AIS. Partial or complete loss of PTEN was demonstrated in 88.8{\%} of AC and 30.4{\%} of AIS. A significant trend of increasing EGFR, loss of PTEN, p53 expression and Ki-67 labeling index were observed by histological progression from AAH to invasive AC through AIS. Expression of p-mTOR was associated with smoking status. Conclusions: Activation of mTOR can occur by various stimuli and may be an early event in the carcinogenesis of lung AC, and may be associated with sex and smoking status of the patient.",
keywords = "Adenocarcinoma, Epidermal growth factor receptor, Lung, Mammalian target of rapamycin, Phosphatase and tensin homolog deleted on chromosome ten",
author = "Younghye Kim and Hoiseon Jeong and Aeree Kim and Kim, {Han Kyeom} and Shin, {Bong Kyung}",
year = "2011",
month = "9",
day = "1",
doi = "10.1111/j.1755-9294.2011.01108.x",
language = "English",
volume = "4",
pages = "78--85",
journal = "Basic and Applied Pathology",
issn = "1755-9294",
publisher = "Wiley-VCH Verlag",
number = "3",

}

TY - JOUR

T1 - Frequent activation of mammalian target of rapamycin in primary lung adenocarcinoma and preinvasive lesion

AU - Kim, Younghye

AU - Jeong, Hoiseon

AU - Kim, Aeree

AU - Kim, Han Kyeom

AU - Shin, Bong Kyung

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Background and aim: The mammalian target of rapamycin (mTOR) pathway is important for cell survival, growth and proliferation and may be involved in the histological progression of lung adenocarcinoma (AC). Methods: We compared the expression of the mTOR signal pathway molecules, i.e., phosphorylated m-TOR (p-mTOR), phosphatase and tensin homolog deleted on chromosome ten (PTEN), epidermal growth factor receptor (EGFR), and cyclin D1, among lung AC, adenocarcinoma in situ (AIS) including both pure bronchioloalveolar carcinoma (BAC) and peripheral BAC-like lesions around invasive carcinoma, atypical adenomatous hyperplasia (AAH), and normal parenchyma surrounding tumor by immunohistochemistry. The protein expression was also correlated with patients' clinicopathological data on smoking history, tumor stage at diagnosis, recurrence and survival. Results: Intermediate or strong immunoreactivity for p-mTOR was seen in 84.1% of AC and 90.2% of AIS. Partial or complete loss of PTEN was demonstrated in 88.8% of AC and 30.4% of AIS. A significant trend of increasing EGFR, loss of PTEN, p53 expression and Ki-67 labeling index were observed by histological progression from AAH to invasive AC through AIS. Expression of p-mTOR was associated with smoking status. Conclusions: Activation of mTOR can occur by various stimuli and may be an early event in the carcinogenesis of lung AC, and may be associated with sex and smoking status of the patient.

AB - Background and aim: The mammalian target of rapamycin (mTOR) pathway is important for cell survival, growth and proliferation and may be involved in the histological progression of lung adenocarcinoma (AC). Methods: We compared the expression of the mTOR signal pathway molecules, i.e., phosphorylated m-TOR (p-mTOR), phosphatase and tensin homolog deleted on chromosome ten (PTEN), epidermal growth factor receptor (EGFR), and cyclin D1, among lung AC, adenocarcinoma in situ (AIS) including both pure bronchioloalveolar carcinoma (BAC) and peripheral BAC-like lesions around invasive carcinoma, atypical adenomatous hyperplasia (AAH), and normal parenchyma surrounding tumor by immunohistochemistry. The protein expression was also correlated with patients' clinicopathological data on smoking history, tumor stage at diagnosis, recurrence and survival. Results: Intermediate or strong immunoreactivity for p-mTOR was seen in 84.1% of AC and 90.2% of AIS. Partial or complete loss of PTEN was demonstrated in 88.8% of AC and 30.4% of AIS. A significant trend of increasing EGFR, loss of PTEN, p53 expression and Ki-67 labeling index were observed by histological progression from AAH to invasive AC through AIS. Expression of p-mTOR was associated with smoking status. Conclusions: Activation of mTOR can occur by various stimuli and may be an early event in the carcinogenesis of lung AC, and may be associated with sex and smoking status of the patient.

KW - Adenocarcinoma

KW - Epidermal growth factor receptor

KW - Lung

KW - Mammalian target of rapamycin

KW - Phosphatase and tensin homolog deleted on chromosome ten

UR - http://www.scopus.com/inward/record.url?scp=80053165916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053165916&partnerID=8YFLogxK

U2 - 10.1111/j.1755-9294.2011.01108.x

DO - 10.1111/j.1755-9294.2011.01108.x

M3 - Article

AN - SCOPUS:80053165916

VL - 4

SP - 78

EP - 85

JO - Basic and Applied Pathology

JF - Basic and Applied Pathology

SN - 1755-9294

IS - 3

ER -